Bristol-Myers Squibb Company (NYSE:BMY) Quarterly Analytical Analysis

Author

26 May, 2017

AlphaOne also gave news stories about the biopharmaceutical company an impact score of 84 out of 100, meaning that recent news coverage is very likely to have an effect on the stock's share price in the next few days. The Rosenblum Silverman Sutton S F Inc holds 8,885 shares with $519,000 value, down from 26,575 last quarter.

Western Digital Corporation (NASDAQ:WDC) shares were last seen up 1.90% at $89.70, which is 24.96% higher than the previous trading session. About shares traded. Magna International Inc. Renn Fund Inc (NYSEMKT:RCG) has risen 13.10% since May 25, 2016 and is uptrending. It has underperformed by 59.88% the S&P500.

Hartford Investment Management Co.'s holdings in Bristol-Myers Squibb were worth $23,362,000 as of its most recent SEC filing.

Bristol-Myers Squibb Company (BMY) now has P/E (Price to Earnings) ratio of 18.8 while the company's industry has 14.29 P/E and the sector P/E is 17.36. Generation Mgmt Limited Liability Partnership accumulated 1.20 million shares.

Shares of Bristol-Myers Squibb Co (NYSE:BMY) opened at 54.39 on Friday. The stock decreased 0.72% or $0.39 during the last trading session, reaching $53.82. About 2.07M shares traded. It has underperformed by 39.89% the S&P500. Its down 0.16, from 1.13 in 2016Q3. IFC Holdings Incorporated FL now owns 10,331 shares of the biopharmaceutical company's stock worth $556,000 after buying an additional 1,485 shares during the period. Fred Alger holds 9,549 shares. Telos Capital invested in 14,121 shares. Moreover, Advisors Asset Management Inc. has 0.02% invested in the company for 96,335 shares. Laurion Capital Management Lp, a New York-based fund reported 48,165 shares. Amazon.com, Inc. (AMZN) shares have moved 3.77% in the week and 8.01% in the month. Robeco Institutional Asset Bv holds 0.03% or 55,793 shares in its portfolio. Reilly Limited Liability Co invested in 0.04% or 3,947 shares. Eagle Ridge Investment has 6,082 shares for 0.07% of their portfolio. Glg Partners Ltd Partnership has 0.09% invested in Amgen, Inc. Pitcairn has 0.08% invested in Becton Dickinson and Co (NYSE:BDX). Jefferies Group LLC reiterated a "buy" rating and issued a $66.00 price objective (up previously from $64.00) on shares of Bristol-Myers Squibb in a report on Saturday, March 11th. 357 were accumulated by Earnest Prtn Ltd Liability. 19,550 were reported by Ccm Investment Advisers Llc. Independent Portfolio Consultants reported 0.62% of its portfolio in Amgen, Inc. Equities analysts predict that Bristol-Myers Squibb Co will post $2.95 earnings per share for the current year. AMGN's profit will be $2.28B for 12.54 P/E if the $3.09 EPS becomes a reality.

The company has mean EPS estimate of 0.75 reported by 17 number of analyst for the quarter ending Jul 26, 2017- Jul 31, 2017. Allergan Plc was raised too.

Among 19 analysts covering Amgen Inc. Therefore 42% are positive. Amgen Inc. had 33 analyst reports since August 3, 2015 according to SRatingsIntel. BlackRock Inc. now owns 97,086,738 shares of the biopharmaceutical company's stock worth $5,279,576,000 after buying an additional 93,075,233 shares during the period.

The company also recently announced a quarterly dividend, which was paid on Monday, May 1st. The firm has "Buy" rating by Guggenheim given on Wednesday, December 2. The stock of Amgen, Inc. The company was maintained on Tuesday, September 20 by Citigroup. The stock of Becton Dickinson and Co (NYSE:BDX) has "Outperform" rating given on Thursday, January 5 by Raymond James. The rating was maintained by Deutsche Bank with "Hold" on Friday, October 28. Therefore 41% are positive. The firm earned "Outperform" rating on Monday, May 9 by Credit Suisse. Bristol-Myers Squibb has a 52-week low of $46.01 and a 52-week high of $77.12. The firm has "Equal Weight" rating by Barclays Capital given on Tuesday, December 1. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating and eleven have issued a buy rating to the company. The rating was maintained by Jefferies with "Hold" on Tuesday, June 14. Morgan Stanley downgraded the stock to "Equal-Weight" rating in Friday, August 5 report. Atlantic Securities has "Underweight" rating and $57 target. It is up 0.00% since May 26, 2016 and is. It is negative, as 86 investors sold BMY shares while 529 reduced holdings. Bender Robert & Associates raised its stake in Bristol-Myers Squibb by 2.7% in the third quarter.

Bristol-Myers Squibb Company (BMY) reported earning per shares for the quarter ending April 27 BMO at 0.84, whereas, 17 number of analysts estimated the mean EPS at 0.73. Caldarella Joseph C also sold $463,779 worth of Bristol-Myers Squibb Co (NYSE:BMY) shares. Sector Gamma As invested in 449,290 shares. Prelude Capital Management Limited Liability Co holds 0.08% or 11,022 shares in its portfolio. Pinebridge Invs Ltd Partnership owns 12,786 shares or 0.02% of their USA portfolio. Arizona-based Mutual Of Omaha Comml Bank Wealth Mgmt has invested 0.7% in Bristol-Myers Squibb Co (NYSE:BMY). Chesapeake Asset Mngmt Limited Liability holds 0.24% in Bristol-Myers Squibb Co (NYSE:BMY) or 4,718 shares. Saturna Capital Corp reported 1.41% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


More news